Home African Swine Fever [Vaccine] Vaccine
African Swine Fever roadmap:
Vaccines

Roadmap for the development of a candidate vaccine for ASF

Download ASF Vaccine Roadmap

1

Vaccine

Dependencies

Vaccine

Research Question

  • Highly efficacious and safe
  • Rapid onset of immunity
  • Long lasting protection following one shot immunisation (at least 1-year)
  • Cross-protection against the various ASFV virus strains
  • No reversion to virulence
  • Virus eradication from a herd or a population
  • Oral administration for wild suids

Research Gaps and Challenges

  • Even homologous protective immunity is very difficult to achieve
  • Cross-protection against the various isolates (heterologous protection)
  • Generation of both a CTC and VN response
  • The dominant immunogens may not be protective

Solution Routes

  • Establish protection levels with various candidate vaccine options, including priming with one vaccine and boosting with a different vaccine
  • Establish if pig genetics influences responses

Dependencies

  • Development of an attenuated vaccine that doesn’t persist or is excreted
  • Development of a subunit vaccine
  • Development of a vector vaccine
  • Development of a DNA vaccine

State Of the Art

  • Several prototypes are presented, but all are far away from a real vaccine candidate

Projects

What activities are planned or underway?

African Swine Fever virus inactivation by feed additives in vitro

Planned Completion date 01/01/2022

Source Countries:

NetherlandsIconNetherlands

The incursion risk of African swine fever for the Netherlands by human-mediated routes

Planned Completion date 01/01/2022

Source Countries:

NetherlandsIconNetherlands